No Data
No Data
European Equities Traded in the US as American Depositary Receipts Trend Lower Wednesday
Trinity Biotech Acquires Metabolomics Diagnostics; Shares Rise After Hours
Trinity Acquires Preeclampsia Test Developer Metabolomics
Trinity Biotech: Dr. Robin Tuytten Will Join Management Team and Continue to Serve as Director of Metabolomic Diagnostics >TRIB
Trinity Biotech's Deal Values Metabolomics Diagnostics With An Enterprise Value Of ~$1.3M With The Consideration Consisting Of Just Over 270,000 Trinity Biotech's ADS With The Balance Of Consideration Being In Cash And The Assumption Of Liabilities
Trinity Biotech: Metabolomics Diagnostics Developed Test, PrePsia, to Accurately Predict Risk of Preeclampsia in Pregnant Women >TRIB